当前位置：首页 > 文献互助 > 互助详情

Abstract A015: JAB-BX600, a first-in-class EGFR-directed antiboEdy drug conjugate delivering a novel KRAS G12D inhibitor复制

用户iQXgRwYGcNXs 44分钟前 7 20 已关闭

DOI: 10.1158/1557-3265.d32026-a015复制

文献链接: https://aacrjournals.org/clincancerres/article/32/14_Supplement/A015/786726/Abstract-A015-JAB-BX600-a-first-in-class-EGFR复制

其他信息:

出版社: American Association for Cancer Research (AACR)
作者: Peng Wang; Fangjie Liu; Xiaoyu Liu; Haijun Li; Xueting He; Amin Li; Andrea Wang-Gillam; Xin Sun; Yiwei Lin; Yanping Wang
全文下载地址: https://aacrjournals.org/clincancerres/article/32/14_Supplement/A015/786726/Abstract-A015-JAB-BX600-a-first-in-class-EGFR

需要全文

上一篇：The Virtual Biotech: A multi-agent AI framework for therapeutic discovery and development

下一篇：High-entropy effect of a metal phosphide on enhanced overall water splitting performance

互助时间线

2026-09-22 13:40:59 [关闭求助]

系统关闭了求助

备注: 显示free已经是全文了 没有下载选项 直接看网页哦

2026-09-22 13:10:27 [发起求助]

最新发布的求助

[47] Gluconokinase: Gluconate+ ATP→ 6-Phosphogluconate+ ADP 3分钟前
Unveiling the Small Molecules Binding Site of CD36 Cell Surface Receptor Through Docking and Molecular Dynamics Simulations 8分钟前
Met, metastasis, motility and more 12分钟前
De novo discovery of a potent ROR1-binding macrocyclic peptide and its evaluation as a novel imaging probe 14分钟前
High-entropy effect of a metal phosphide on enhanced overall water splitting performance 27分钟前
Abstract A015: JAB-BX600, a first-in-class EGFR-directed antiboEdy drug conjugate delivering a novel KRAS G12D inhibitor 44分钟前
The Virtual Biotech: A multi-agent AI framework for therapeutic discovery and development 56分钟前
Functional characterisation of gluconate kinase and its role in human cell metabolism 2小时前
Solubilization of aluminum-containing adjuvants by constituents of interstitial fluid 2小时前
Unraveling the mechanisms of NINJ1-mediated plasma membrane rupture in lytic cell death and related diseases 2小时前
Crystallinity-guided hybrid conversion for efficient ultrawide-bandgap perovskites in triple-junction solar cells 2小时前
Orforglipron compared with dapagliflozin in adults with type 2 diabetes and inadequate glycaemic control with metformin (ACHIEVE-2): a multicentre, randomised, non-inferiority, open-label, phase 3 trial 3小时前

wispass工作室 Copyright © 蜀ICP备20005939号-4 www.wispass.com